Epigenetic mosaicism and cell burden in Beckwith–Wiedemann syndrome due to loss of methylation at imprinting control region 2
Molecular Case Studies · 2021-12 · 7 (6) · a006115
DOI: 10.1101/mcs.a006115 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Case Studies, online erschienen am 25.10.2021. Verfasst von Kelly A Duffy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA. Hauptthemen laut MEDLINE: Beckwith-Wiedemann Syndrome. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Beckwith–Wiedemann syndrome (BWS) is a rare overgrowth disorder caused by epigenetic alterations on Chromosome 11p15.5. Most molecular changes are sporadic and are thought to occur in a mosaic pattern. Thereby, the distribution of affected cells differs between tissues for each individual, which can complicate genotype–phenotype correlations. In two of the BWS molecular subtypes, tissue mosaicism has been demonstrated; however, mosaicism has not been specifically studied in the most common cause of BWS, loss of methylation (LOM) at KCNQ1OT1: TSS differentially methylated region (DMR) imprinting center 2 (IC2) LOM. The increased prevalence of twinning associated with the IC2 LOM subtype and the discordant phenotypes between the twins previously led to the proposal of diffused epigenetic mosaicism, leading to asymmetric distribution of affected cells during embryonic development. In this study, we evaluated the level of methylation detected in 64 samples collected from 30 individuals with IC2 LOM. We demonstrate that the IC2 LOM defect can occur in mosaic and nonmosaic patterns, and tissues from the same individual can show variable patterns, which suggests that this asymmetric distribution occurs during development. We further suggest that the clinical phenotype in individuals with BWS IC2 LOM is correlated with the epigenetic burden of affected cells in each tissue type. This series is the first report to demonstrate tissue mosaicism within the IC2 LOM epigenotype, and consideration of this mosaicism is necessary to understanding the pathogenesis of BWS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA.
- Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
- Department of Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
- Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA.
ORCID-Profile: Kelly A Duffy, Jennifer M Kalish
Zitieren
APA
Duffy, K. A., Hathaway, E. R., Klein, S. D., Ganguly, A., & Kalish, J. M. (2021). Epigenetic mosaicism and cell burden in Beckwith–Wiedemann syndrome due to loss of methylation at imprinting control region 2. Molecular Case Studies, 7(6), a006115. https://doi.org/10.1101/mcs.a006115
Vancouver
Duffy KA, Hathaway ER, Klein SD, Ganguly A, Kalish JM. Epigenetic mosaicism and cell burden in Beckwith–Wiedemann syndrome due to loss of methylation at imprinting control region 2. Molecular Case Studies. 2021;7(6):a006115. doi:10.1101/mcs.a006115
BibTeX
@article{Duffy2021,
author = {Duffy, Kelly A and Hathaway, Evan R and Klein, Steven D and Ganguly, Arupa and Kalish, Jennifer M},
title = {Epigenetic mosaicism and cell burden in Beckwith–Wiedemann syndrome due to loss of methylation at imprinting control region 2},
journal = {Molecular Case Studies},
year = {2021},
volume = {7},
number = {6},
pages = {a006115},
doi = {10.1101/mcs.a006115}
}
EUVIMED